Skip to content

Clinical trials

Withdrawn Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Withdrawn Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20075
20082
20092
20101
20112
20121
20131
20141
20161
20172
20192
20201
20211
20222
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center4
Mayo Clinic2
Alliance for Clinical Trials in Oncology1
Antonios Likourezos1
CSA Medical, Inc.1
ECOG-ACRIN Cancer Research Group1
First Affiliated Hospital Xi'an Jiaotong University1
Global BioClinical1
Guangdong Provincial People's Hospital1
Holy Cross Hospital, Maryland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms34
Carcinoma, Non-Small-Cell Lung10
Breast Neoplasms5
Small Cell Lung Carcinoma4
Esophageal Neoplasms3
Melanoma3
Neoplasm Metastasis3
Prostatic Neoplasms3
Colorectal Neoplasms2
Lung Diseases2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.